Prana commences research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology July 18, 2017August 16, 2022
Prana’s Huntington Disease trial analysis to feature at global movement disorder conference June 22, 2016August 16, 2022
Prana’s Anti-Parkinsonian compound PBT434 presented at 13th International Conference for Alzheimer’s & Parkinson’s Diseases March 30, 2017August 16, 2022